TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioEndev AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
1,892
|
420 |
Financial expenses |
116
|
127
|
98 |
Earnings before taxes |
4,689
|
-962
|
-9,512 |
EBITDA |
-188
|
-1,181
|
-9,415 |
Total assets |
5,289
|
31,736
|
48,833 |
Current assets |
4,879
|
30,318
|
47,371 |
Current liabilities |
116
|
4,172
|
11,134 |
Equity capital |
5,173
|
27,564
|
29,410 |
- share capital |
483
|
451
|
465 |
Employees (average) |
0
|
1
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
97.8%
|
86.9%
|
60.2% |
Turnover per employee |
1,892
|
210 | |
Profit as a percentage of turnover |
-50.8%
|
-2264.8% | |
Return on assets (ROA) |
90.8%
|
-2.6%
|
-19.3% |
Current ratio |
4206.0%
|
726.7%
|
425.5% |
Return on equity (ROE) |
90.6%
|
-3.5%
|
-32.3% |
Change turnover |
-2,026
|
1,484
|
-67 |
Change turnover % |
-100%
|
364%
|
-14% |
Chg. No. of employees |
-1
![]() |
-1
![]() |
-1 |
Chg. No. of employees % |
-100%
|
-50%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.